Skip to main content
Dr.Agarwals Eye Hospital Ltd. logo

Dr.Agarwals Eye Hospital Ltd. — Investor Relations & Filings

Ticker · DRAGARWQ ISIN · INE934C01018 BSE.NS Human health and social work activities
Open in API
Filings indexed 5 across all filing types
Latest filing 2026-05-20 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS DRAGARWQ

About Dr.Agarwals Eye Hospital Ltd.

https://www.dragarwal.com

Dr. Agarwals Eye Hospital Ltd. is a leading provider of comprehensive eye care services, specializing in advanced tertiary ophthalmic treatments. Established in 1957, the organization operates an extensive network of specialized hospitals. Its clinical portfolio encompasses a wide range of services, including cataract surgery, refractive errors correction (LASIK and SMILE), vitreoretinal surgery, glaucoma management, pediatric ophthalmology, and corneal transplantation. The institution is recognized for its pioneering surgical innovations, such as the Glued Intraocular Lens (IOL) technique and Pre-Descemet's Endothelial Keratoplasty (PDEK). Utilizing state-of-the-art diagnostic and surgical technologies, the hospital focuses on delivering high-precision clinical outcomes. Its service model integrates specialized clinics for diabetic retinopathy and neuro-ophthalmology, catering to complex ocular conditions through a patient-centric approach.

Recent filings

Filing Released Lang Actions
Declaration of Final Dividend of Rs 4/- per equity share of Rs. 10 each for the financial year ended March 31, 2026.
Interim / Quarterly Report Classification · 85% confidence The document is a Board meeting outcome under SEBI Regulation 30 announcing and enclosing the audited financial results for the quarter and year ended March 31, 2026, together with the Statutory Auditor’s report and full financial statements. It is not a mere earnings summary (ER) nor a full Annual Report (10-K), but contains comprehensive period‐to‐date financial data and statutory audit opinion for a period shorter than a full fiscal year (quarter) along with year‐end results. This matches the definition for an Interim/Quarterly Report (IR). FY 2026
2026-05-20 English
Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Declaration of Final Dividend for the financial year ended March 31, 2026, is attached
Interim / Quarterly Report Classification · 90% confidence The document is a Board meeting outcome letter filed under SEBI Listing Regulations that includes the audited financial results for the quarter and year ended March 31, 2026, together with the independent auditor’s report and detailed financial statements. It is not merely a brief earnings release or dividend notice, nor is it a full Annual Report; rather, it is a comprehensive financial report for a period shorter than a full fiscal year (along with the year‐end audited results) filed as required. This fits the definition of an Interim/Quarterly Report (Code: IR). FY 2026
2026-05-20 English
Audited Financial Results of the Company for the quarter and year ended March 31, 2026, is attached.
Regulatory Filings Classification · 20% confidence The document is a formal notification under Regulation 30 of SEBI’s Listing Obligations, describing the outcome of the Board meeting held on May 20, 2026. It encloses the Audited Financial Results for the quarter and year ended March 31, 2026, includes the Statutory Auditor’s report and CFO declaration, and recommends a final dividend. It is not a full Annual Report (10-K) nor solely a management discussion, nor is it merely an announcement of report availability. It is a regulatory filing under Indian SEBI LODR rules, making it a general regulatory announcement (fallback category).
2026-05-20 English
Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve The Audited Financial ....
Regulatory Filings Classification · 85% confidence The document is a formal SEBI LODR Regulation 29 intimation of an upcoming board meeting to consider and approve audited financial results and potential dividend. It does not contain the results themselves, nor is it a notice of dividend amount. It is not a board change announcement, but a general regulatory disclosure. Therefore, it fits the fallback category “Regulatory Filings (RNS)” for miscellaneous compliance announcements.
2026-05-14 English
Receipt of Order passed by the Hon''ble NCLT, Chennai Bench, in relation to the Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care Limited, is attached.
M&A Activity Classification · 88% confidence The document is an official stock exchange filing under SEBI regulations describing receipt of an NCLT order for convening meetings to approve a Scheme of Amalgamation between two entities (AEHL and AHCL). It is announcing the next steps in a merger process. This clearly relates to M&A Activity, not a financial report or AGM materials. Therefore, the appropriate category is M&A Activity (TAR).
2026-05-11 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.